Nature Biotechnology 24, 227 - 228 (2006)
Published online: 8 March 2006; | doi:10.1038/nbt0306-227
Deconstructing Myogen's market capJohn Ransom
Lone Tree, Colorado
The best-performing stock from 2005 was a prime example of how biotech stocks are not as capricious as they may seem.
|
